IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 62 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $79,000 | -14.1% | 77,044 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $92,000 | -8.0% | 77,044 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $100,000 | -64.7% | 77,044 | 0.0% | 0.01% | -60.0% |
| Q4 2020 | $283,000 | +71.5% | 77,044 | 0.0% | 0.02% | +66.7% |
| Q3 2020 | $165,000 | +19.6% | 77,044 | 0.0% | 0.01% | +12.5% |
| Q2 2020 | $138,000 | +35.3% | 77,044 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $102,000 | -27.1% | 77,044 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $140,000 | -37.2% | 77,044 | 0.0% | 0.01% | -46.7% |
| Q3 2019 | $223,000 | +8.3% | 77,044 | 0.0% | 0.02% | +50.0% |
| Q2 2019 | $206,000 | +5.1% | 77,044 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $196,000 | -8.0% | 77,044 | 0.0% | 0.01% | -27.3% |
| Q4 2018 | $213,000 | -69.0% | 77,044 | 0.0% | 0.01% | -60.7% |
| Q3 2018 | $686,000 | – | 77,044 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |